(2,5-Dioxopyrrolidin-1-yl) 2-[2-[2-[(2,5-dioxopyrrolidin-1-yl)oxycarbonylamino]oxyethoxy]ethoxy]acetate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: (2,5-Dioxopyrrolidin-1-yl) 2-[2-[2-[(2,5-dioxopyrrolidin-1-yl)oxycarbonylamino]oxyethoxy]ethoxy]acetate
• 英文别名: (2,5-dioxopyrrolidin-1-yl) 2-[2-[2-[(2,5-dioxopyrrolidin-1-yl)oxycarbonylamino]oxyethoxy]ethoxy]acetate
• 化学式: C₁₅H₁₉N₃O₁₁
• 分子量: 417.32
• InChiKey: NMZBMUIMNUUMCT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.2
• 重原子数：
  29
• 可旋转键数：
  13
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  167
• 氢给体数：
  1
• 氢受体数：
  11

文献信息

• [EN] DENDRITIC CORE COMPOUNDS<br/>[FR] COMPOSÉS À CŒUR DENDRITIQUE
  申请人：CALLAGHAN INNOVATION RES LTD

  公开号：WO2014084743A1

  公开（公告）日：2014-06-05

  The invention relates to compounds that are useful for the preparation of dendrimer compounds, the use of these compounds for preparing dendrimers and processes for preparing the compounds.

  本发明涉及用于制备树枝状化合物有用的化合物，以及使用这些化合物来制备树枝状化合物的方法以及制备这些化合物的过程。
• DENDRITIC CORE COMPOUNDS
  申请人：VICTORIA LINK LIMITED

  公开号：US20150291522A1

  公开（公告）日：2015-10-15

  The invention relates to compounds that are useful for the preparation of dendrimer compounds, the use of these compounds for preparing dendrimers and processes for preparing the compounds.
• Saccharide Dendritic Cluster Compounds as Inhibitors of Bace-1
  申请人：VICTORIA LINK LIMITED

  公开号：US20150291644A1

  公开（公告）日：2015-10-15

  The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical compositions containing the compounds, processes for preparing the compounds, and methods of treating diseases or conditions in which it is desirable to inhibit β-secretase.
• [EN] SACCHARIDE DENDRITIC CLUSTER COMPOUNDS AS INHIBITORS OF BACE-1<br/>[FR] COMPOSÉS AGGLOMÉRÉS DENDRITIQUES SACCHARIDIQUES COMME INHIBITEURS DE BACE-1
  申请人：CALLAGHAN INNOVATION RES LTD

  公开号：WO2014084744A1

  公开（公告）日：2014-06-05

  The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical compositions containing the compounds, processes for preparing the compounds, and methods of treating diseases or conditions in which it is desirable to inhibit β-secretase.